Omega Healthcare price target raised to $33 from $32 at Truist

Truist analyst Michael Lewis raised the firm’s price target on Omega Healthcare to $33 from $32 and keeps a Hold rating on the shares. The firm is updating its model as the remaining Guardian properties were sold in April, and it appears that Omega Healthcare may be positioned for a “palatable and successful LaVie resolution”, though an earnings rebound is already largely priced into the stock, the analyst tells investors in a research note.